Patients rarely consult physicians before developing coagulopathy or bleeding in most reported cases of superwarfarin intoxication. A 57-year-old woman ingested red-dyed pellets of anticoagulant rodenticide containing difethialone and warfarin as well as tablets of nitrazepam. Although she presented to the hospital in a comatose state, notable pink-colored excreta hinted at the consumption of anticoagulant rodenticide, which led to the early diagnosis of superwarfarin intoxication. Supplementation of large doses of intravenous and oral vitamin K successfully prevented coagulopathy and bleeding. On the other hand, temporary and reversible myocardial suppression was extremely severe, and required the introduction of percutaneous cardiopulmonary support.
Introduction
Superwarfarins, which were developed in the 1970s to overcome warfarin -resistance acquired by mice and rats, are widely used as household anticoagulant rodenticides. We report a case of anticoagulant rodenticide intoxication with a previously unreported clinical presentation characterized by notable pink-colored excreta and severe myocardial suppression.
Case Report
A 57-year-old schizophrenic woman, who had not taken her prescribed schizophrenia drugs for several weeks, was brought to the Emergency Center at 10:49 PM. On arrival, she was comatose with vital signs as follows: blood pressure 130/70 mm Hg, heart rate 133 bpm, respiratory rate 12/minute (shallow), and body temperature 35.8 . She demonstrated incontinence with pink urine (Fig. 1 ) and pinkcolored muddy stool, as well as pink-colored vomit around her mouth. Laboratory tests revealed respiratory acidosis (pH 7.140, PaO2 299.8 mm Hg, PaCO2 79.5 mm Hg, HCO3 26.5 mmol/L, base excess -4.7 mmol/L), inspiration of 8 L/ min of O2 through a non-rebreather oxygen face mask with a reservoir, and hyper-creatine kinasemia (CK 1,407 IU/L). Tests for occult blood and bilirubin in urine were negative. Other laboratory tests, including international normalized ratio (INR) of 1.12 and activated partial thromboplastin time (aPTT) of 31.3 seconds, were unremarkable (Table 1) . Triage DOA (Biosite Diagnostics, San Diego, CA) detected benzodiazepines.
She was intubated and mechanically ventilated, and 50 g of activated charcoal was administered through a nasogastric tube. Although benzodiazepine intoxication was suspected, notable pink-colored excreta suggested the possibility that she ingested other agents. We requested that her family search the house, and five empty boxes of household rodenticide were found. Of these five boxes, two included 120 g of red-dyed pellets containing 0.0025% difethialone (corresponding to 3 mg), and the other three included 360 g of red-dyed pellets containing 0.05% warfarin (corresponding to 180 mg).
On the morning of day 2, her INR and aPTT rose to 1.8 and 43.6 seconds, respectively, and 10 mg of intravenous vitamin K was administered. However, in the afternoon, her INR and aPTT further worsened to 2.65 and>200 seconds, respectively. Another 10 mg of intravenous vitamin K was administered, and a continuous infusion of intravenous vitamin K at a rate of 10 mg/hr was initiated at 3:40 PM. On the other hand, her systolic blood pressure decreased to 40 mm Hg in the morning without responding to even high doses of intravenous catecholamines. An echocardiogram, at approximately 8:00 AM, revealed diffuse myocardial hypokinesia with a left ventricular ejection fraction (LVEF) of 34.4%. At 9:30 AM, a percutaneous cardiopulmonary support (PCPS) was introduced. Myocardial function deteriorated further, resulting in diffuse myocardial akinesia with a LVEF of almost 0% at 0:45 PM. Intra-aortic balloon pumping (IABP) was initiated at 2:20 PM. Her myocardial function began to improve in the evening with a LVEF of 30% at 9:00 PM.
On day 3, an echocardiogram at 5:00 AM detected a LVEF of 70.3% with no distinctive asynergy. PCPS and IABP were terminated at 2:30 PM and 11:30 PM, respectively. On day 5, she was released from mechanical ventilation and detubated, as her physical state, including consciousness, had fully improved (Fig. 2) . On day 8, intravenous vitamin K was changed to 10 mg of oral vitamin K daily, resulting in approximately 963 mg of total intravenous vitamin K. On day 21, she displayed normal INR and aPTT, and was transferred to the psychiatric department of another hospital without having developed hemorrhagic complications.
The patient later confessed that she intentionally ingested the five boxes of household rodenticide and 28 tablets of nitrazepam (corresponding to 280 mg) at approximately 8:00 PM on day 1. Serum concentrations of difethialone, warfarin, and nitrazepam, determined by high performance liquid chromatography (HPLC), were 191.8 ng/mL, 17.53 μg/ mL (therapeutic: 1 to 7 μg/mL, toxic: 10 to 12 μg/mL), and 1.3 μg/mL (therapeutic: 0.03 to 0.1 μg/mL, toxic: 0.2 to 3 μg/mL), respectively, at the time of admission. Toxicological screening tests using HPLC did not reveal any other agents. Serum difenthialone concentration rapidly decreased to 88.4 ng/mL in about 12 hours (Fig. 1) .
Discussion
Vitamin K-dependent coagulation factors (II, VII, IX, X, protein C, and protein S) are synthesized in an inactive form, which is converted to the active form by γ-carboxylation of glutamic residues, in a vitamin Kdependent reaction. As a result, the active vitamin K is converted to an inactive vitamin K epoxide. Superwarfarin and warfarin inhibit the action of vitamin K epoxide reductase, which converts vitamin K epoxide back to vitamin K, thereby causing a deficiency of vitamin K. Superwarfarins are highly lipophilic, long-acting, and 100 times more potent than warfarin (1) . Superwarfarin intoxication, due to accidental ingestion by children or intentional ingestion by adults with Munchausen syndrome or attempting suicide, results in coagulopathy or bleeding from multiple sites (2-6). Since the strong anticoagulant effects of superwarfarin intoxication last for weeks or months, prolonged administration of large doses of vitamin K is necessary (7, 8) .
Patients rarely consult physicians before developing coagulopathy or bleeding in most reported cases of superwarfarin intoxication (2) (3) (4) (5) (6) (7) (8) . In the present case, the patient ingested red-dyed pellets of an anticoagulant rodenticide containing 3 mg of difethialone (a superwarfarin) and 180 mg of warfarin, as well as tablets of nitrazepam, a benzodiazepine. Although she arrived at the hospital in a comatose state, notable pink-colored excreta hinted at the consumption of anticoagulant rodenticide, which led to the early diagnosis of superwarfarin intoxication. Supplementation of large doses of intravenous and oral vitamin K under strict monitoring of INR and aPTT successfully prevented coagulopathy and bleeding. Serum concentrations of warfarin and nitrazepam at admission were both toxic (9) . Difethialone levels were also toxic, as 35 ng/mL of serum difethialone was detected in a case of an adult woman who ingested the anticoagulant superwarfarin, resulting in hemorrhagic complications (4). Anticoagulant rodenticide intoxication should be considered if pink or blue-colored excreta are observed, as pellets of anticoagulant rodenticide are usually colored with red or blue dyes.
On the other hand, temporary and reversible myocardial suppression was extremely severe, and required introduction of PCPS and IABP. Neither massive infusion nor drugs other than vitamin K had been administered prior to noticing myocardial suppression. Accordingly, we suspected the contribution of intentionally ingested agents. There are no reports of serious cardiac toxicity due to superwarfarin, warfarin, and nitrazepam. Reports of intoxication by warfarin and nitrazepam, which have been used as medical drugs for many years, are numerous and preclude the involvement of these agents in serious cardiac toxicity. On the other hand, reports of difethialone intoxication are limited, thus difethialone-induced toxicity cannot be ruled out. Most superwarfarins, including brodifacoum, difenacoum, and bromadiolone, are 4-hydroxy-coumarin derivatives. Difethialone 
international normalized ratio; aPTT, activ WBC, white blood cells; Hb, hemoglobin; Plt, platelets; PT, prothrombin; INR, ated partial thromboplastin time; FIB, fibrinogen; TP, total protein; Alb, albumin; BUN, blood urea nitrogen; Cr, creatinine; T-Bil, total bilirubin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; CK, creatinine kinase; CRP, C-reactive protein is derived from 4-hydroxybenzothiopyranone, in which the oxygen atom of 4-hydroxy-coumarin is replaced by a sulfur atom. This structural difference may play a role in its cardiac toxicity. Development of myocardial suppression was delayed about half a day after ingestion. This suggests that rather than superwarfarin itself, its toxic metabolites may have an affect on myocardial tissue. Further studies using animal models should be undertaken to investigate cardiac toxicity associated with difethialone.
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